Cholesterol care | New York
Lerochol contains lerodalcibep-liga, an LDL-lowering PCSK9-binding fusion protein. Its December 2025 US label covers adults with hypercholesterolemia, including HeFH. It is not a monoclonal antibody or inclisiran.
Lerodalcibep binds PCSK9 to help the liver remove LDL. The fusion-protein structure differs from the antibodies Repatha and Praluent. Similar targets do not make products or schedules interchangeable.
Adults needing further LDL reduction may be considered after reviewing cardiovascular risk and existing treatment. The label is not a pediatric indication or a separate cardiovascular outcomes indication. Clinical suitability and pharmacy access need separate confirmation.
Review LDL cholesterol and overall cardiovascular risk, including blood pressure, diabetes, smoking, and family history. Check possible secondary causes and current treatment. Discuss food and activity changes, the maximally tolerated statin, and additional therapy when indicated. Choose the medicine and administration method together, then agree on laboratory follow-up and access. The labeled regimen is 300 mg under the skin once monthly. Patients or caregivers need training for the prefilled syringe, storage, and missed-dose instructions.
Bring dated cholesterol panels, all lipid medicines and doses tried, adverse effects, kidney or liver results, and family history of early heart disease. Include any genetic testing, prior heart attack or stroke records, and insurance denials. Outside records can help avoid repeating information.
Review allergies, pregnancy plans, breastfeeding, kidney or liver conditions, and other medicines. Seek emergency care for breathing difficulty or a severe allergic reaction. New unexplained symptoms deserve prescriber advice rather than assuming they are expected. A cholesterol medicine does not treat an acute heart attack or stroke. Confirm supply with the dispensing pharmacy. An address or service card does not show that every Nao clinic stocks or administers Lerochol.
Repeat cholesterol testing on the clinician’s schedule to assess response and adherence. Review side effects, missed doses, and refill access. Taking a cholesterol medicine does not replace laboratory monitoring or the rest of cardiovascular care. Do not stop existing medicines unless the prescriber gives a new plan.
Confirm the exact service, clinician, formulation, appointment, and refill route before booking. The evaluation, tests, medicine, administration, and follow-up may have separate costs and benefits. Ask for current estimates and required records. An FDA-approved drug or a clinic address does not establish pharmacy stock, onsite treatment, coverage, or a prescription. If access changes, contact the treating team before interrupting treatment.
Lerochol contains lerodalcibep-liga, an LDL-lowering PCSK9-binding fusion protein. Its December 2025 US label covers adults with hypercholesterolemia, including HeFH. It is not a monoclonal antibody or inclisiran. Lerodalcibep binds PCSK9 to help the liver remove LDL. The fusion-protein structure differs from the antibodies Repatha and Praluent. Similar targets do not make products or schedules interchangeable.
Review LDL cholesterol and overall cardiovascular risk, including blood pressure, diabetes, smoking, and family history. Check possible secondary causes and current treatment. Discuss food and activity changes, the maximally tolerated statin, and additional therapy when indicated. Choose the medicine and administration method together, then agree on laboratory follow-up and access. The labeled regimen is 300 mg under the skin once monthly. Patients or caregivers need training for the prefilled syringe, storage, and missed-dose instructions.
Repatha, Praluent, or Lerochol may be self-injected after product-specific training when prescribed. Confirm the exact product, device, schedule, and who provides training. A clinic listing does not establish onsite administration. Do not use another medicine’s instructions.
Yes. LIB Therapeutics announced the US commercial launch of Lerochol on May 11, 2026. As of October 9, 2026, it is a marketed prescription medicine, including a manufacturer direct-to-patient route for eligible adults. Confirm the exact prescription, pharmacy, cost and training arrangements; launch does not establish supply or injection service at every Nao clinic.
No. Lerochol is a PCSK9-binding fusion protein. Repatha and Praluent are monoclonal antibodies, and Leqvio is small interfering RNA. These treatments target related biology but are different products.
FDA approval, manufacturer supply, a pharmacy’s ability to fill the exact strength, and Nao Medical service availability are different questions. Confirm the exact product and refill route before a treatment change. Local supply can vary. Call before traveling, and do not interrupt prescribed treatment based on a website listing.
Bring dated cholesterol panels, all lipid medicines and doses tried, adverse effects, kidney or liver results, and family history of early heart disease. Include any genetic testing, prior heart attack or stroke records, and insurance denials. Outside records can help avoid repeating information.
The visit should establish the patient's LDL level and goal, cardiovascular and family history, prior and current treatment, adherence, allergies, pregnancy or lactation considerations, and whether a monthly self-injection fits the care plan.
The labeled dose is 300 mg by subcutaneous injection once monthly. The patient or caregiver should receive training before self-administration with the prescribed device.
A treatment plan should define lipid reassessment and review injection-site reactions, hypersensitivity, technique, storage, adherence, and response. The full label should guide missed-dose and handling questions.
The visit should establish the patient's LDL level and goal, cardiovascular and family history, prior and current treatment, adherence, allergies, pregnancy or lactation considerations, and whether a monthly self-injection fits the care plan.
A treatment plan should define lipid reassessment and review injection-site reactions, hypersensitivity, technique, storage, adherence, and response. The full label should guide missed-dose and handling questions.
Before starting a self-injected cholesterol medicine, discuss the prescription, pharmacy supply, insurance, storage, injection training and follow-up. A patient or caregiver should receive training before the first self-injection.
An evaluation may lead to another medicine, more testing, a referral, or no medication change.
The health plan and dispensing pharmacy make coverage and fulfillment decisions. Prior authorization may be required.
The clinic cards below show places to start an evaluation. They do not prove that a product is stocked, dispensed, taught, or administered at that site.
Bronx
932 E 174th St, Bronx, NY 10460
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Queens
37-15 23rd Ave, Astoria, NY 11105
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Bronx
2063A Bartow Ave, Bronx, NY 10475
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Brooklyn
341 Eastern Pkwy, Brooklyn, NY 11216
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Long Island
232 W Old Country Rd, Hicksville, NY 11801
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Queens
80-10 Northern Blvd, Jackson Heights, NY 11372
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Queens
90-18 Sutphin Blvd, Jamaica, NY 11435
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Queens
30-07 36th Ave, Astoria, NY 11106
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Long Island
135 Mineola Blvd, Mineola, NY 11501
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Manhattan
259 1st Ave, New York, NY 10003
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Brooklyn
308 Graham Ave, Brooklyn, NY 11211
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Explore broader cardiovascular prevention and cholesterol care at Nao Medical.
Compare established self-injection schedules and label differences.
Review another PCSK9 antibody and its distinct dosing options.
Compare clinician administration with monthly self-injection.
Review inherited high cholesterol before focusing on one medicine.